Abstracts must be:

• based on original research, case reports or reviews and relate to any field of medical writing, communications, editing or translation
• encore abstracts are allowed if presented in relevant conferences in H2-2023 or H1-2024
• structured (Introduction, Methodology, Results, Conclusion) and include fewer than 250 words (excluding title, authors and affiliations)
• submitted in English (UK spelling)
• submitted on the official EMWA submission form (below)
• submitted by e-mail to emwaconference@emwa.org by 17 January 2025, 17:00 GMT by the presenting author

• By submitting an abstract, the authors confirm that the data have NOT been previously published as a full paper and agree that if it is accepted it will be published in the official EMWA journal, Medical Writing (open access, CC-BY). Please note only presented abstracts will be published, if an author is unable to present the abstract will be withdrawn
• All abstracts will be reviewed by an expert panel and may be selected for poster presentation (or rejected)
• Abstract notifications will be sent to authors via email w/c 14 February 2025, together with the poster preparation guidelines (if abstract accepted).
• The presenting author MUST:
• be registered for the conference and present the poster during presentation indicated times
• ensure that all co-authors are aware of, contributed to and agree with the content of the abstract before submission
• state that this condition is met in the submission email

Posters based on accepted abstracts will be displayed at the conference from 6 to 9 May 2025.

Please click here to download the submission form.